BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26073878)

  • 1. 3 Tesla MRI detects deterioration in proximal femur microarchitecture and strength in long-term glucocorticoid users compared with controls.
    Chang G; Rajapakse CS; Regatte RR; Babb J; Saxena A; Belmont HM; Honig S
    J Magn Reson Imaging; 2015 Dec; 42(6):1489-96. PubMed ID: 26073878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-T MR Imaging of Proximal Femur Microarchitecture in Subjects with and without Fragility Fracture and Nonosteoporotic Proximal Femur Bone Mineral Density.
    Chang G; Rajapakse CS; Chen C; Welbeck A; Egol K; Regatte RR; Saha PK; Honig S
    Radiology; 2018 May; 287(2):608-619. PubMed ID: 29457963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3T chemical shift-encoded MRI: Detection of altered proximal femur marrow adipose tissue composition in glucocorticoid users and validation with magnetic resonance spectroscopy.
    Martel D; Leporq B; Saxena A; Belmont HM; Turyan G; Honig S; Regatte RR; Chang G
    J Magn Reson Imaging; 2019 Aug; 50(2):490-496. PubMed ID: 30548522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finite element analysis applied to 3-T MR imaging of proximal femur microarchitecture: lower bone strength in patients with fragility fractures compared with control subjects.
    Chang G; Honig S; Brown R; Deniz CM; Egol KA; Babb JS; Regatte RR; Rajapakse CS
    Radiology; 2014 Aug; 272(2):464-74. PubMed ID: 24689884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced imaging assessment of bone fragility in glucocorticoid-induced osteoporosis.
    Kalpakcioglu BB; Engelke K; Genant HK
    Bone; 2011 Jun; 48(6):1221-31. PubMed ID: 21320651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7 Tesla MRI of bone microarchitecture discriminates between women without and with fragility fractures who do not differ by bone mineral density.
    Chang G; Honig S; Liu Y; Chen C; Chu KK; Rajapakse CS; Egol K; Xia D; Saha PK; Regatte RR
    J Bone Miner Metab; 2015 May; 33(3):285-93. PubMed ID: 24752823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion tensor imaging and magnetic resonance spectroscopy assessment of cancellous bone quality in femoral neck of healthy, osteopenic and osteoporotic subjects at 3T: Preliminary experience.
    Manenti G; Capuani S; Fanucci E; Assako EP; Masala S; Sorge R; Iundusi R; Tarantino U; Simonetti G
    Bone; 2013 Jul; 55(1):7-15. PubMed ID: 23507402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis.
    Chen P; Miller PD; Recker R; Resch H; Rana A; Pavo I; Sipos AA
    J Bone Miner Res; 2007 Aug; 22(8):1173-80. PubMed ID: 17451369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.
    Devogelaer JP; Adler RA; Recknor C; See K; Warner MR; Wong M; Krohn K
    J Rheumatol; 2010 Jan; 37(1):141-8. PubMed ID: 19918047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High resolution quantitative computed tomography-based assessment of trabecular microstructure and strength estimates by finite-element analysis of the spine, but not DXA, reflects vertebral fracture status in men with glucocorticoid-induced osteoporosis.
    Graeff C; Marin F; Petto H; Kayser O; Reisinger A; Peña J; Zysset P; Glüer CC
    Bone; 2013 Feb; 52(2):568-77. PubMed ID: 23149277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass.
    Natsui K; Tanaka K; Suda M; Yasoda A; Sakuma Y; Ozasa A; Ozaki S; Nakao K
    Osteoporos Int; 2006 Jan; 17(1):105-8. PubMed ID: 15886861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subchondral bone microarchitecture analysis in the proximal tibia at 7-T MRI.
    Agten CA; Honig S; Saha PK; Regatte R; Chang G
    Acta Radiol; 2018 Jun; 59(6):716-722. PubMed ID: 28899123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal study on physical fitness parameters influencing bone mineral density reduction in middle-aged and elderly women: bone mineral density in the lumbar spine, femoral neck, and femur.
    Iida T; Ikeda H; Shiokawa M; Aoi S; Ishizaki F; Harada T; Ono Y
    Hiroshima J Med Sci; 2012 Jun; 61(2):23-8. PubMed ID: 22916509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiographic bone texture analysis is correlated with 3D microarchitecture in the femoral head, and improves the estimation of the femoral neck fracture risk when combined with bone mineral density.
    Ollivier M; Le Corroller T; Blanc G; Parratte S; Champsaur P; Chabrand P; Argenson JN
    Eur J Radiol; 2013 Sep; 82(9):1494-8. PubMed ID: 23756323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of proximal femur microarchitecture using ultra-high field MRI at 7 Tesla.
    Guenoun D; Pithioux M; Souplet JC; Guis S; Le Corroller T; Fouré A; Pauly V; Mattei JP; Bernard M; Guye M; Chabrand P; Champsaur P; Bendahan D
    Diagn Interv Imaging; 2020 Jan; 101(1):45-53. PubMed ID: 31331831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement reproducibility of magnetic resonance imaging-based finite element analysis of proximal femur microarchitecture for in vivo assessment of bone strength.
    Chang G; Hotca-Cho A; Rusinek H; Honig S; Mikheev A; Egol K; Regatte RR; Rajapakse CS
    MAGMA; 2015 Aug; 28(4):407-12. PubMed ID: 25487834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.
    Diamond T; McGuigan L; Barbagallo S; Bryant C
    Am J Med; 1995 May; 98(5):459-63. PubMed ID: 7733124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Femoral neck cortical geometry measured with magnetic resonance imaging is associated with proximal femur strength.
    Manske SL; Liu-Ambrose T; de Bakker PM; Liu D; Kontulainen S; Guy P; Oxland TR; McKay HA
    Osteoporos Int; 2006 Oct; 17(10):1539-45. PubMed ID: 16847586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-induced osteoporosis: an update on effects and management.
    Buehring B; Viswanathan R; Binkley N; Busse W
    J Allergy Clin Immunol; 2013 Nov; 132(5):1019-30. PubMed ID: 24176682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR; Ventz M; Diederich S; Quinkler M
    J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.